`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE EASTERN DISTRICT OF TEXAS
`MARSHALL DIVISION
`
`
`
`ALLERGAN, INC., and THE SAINT
`REGIS MOHAWK TRIBE,
`
`
`Plaintiff,
`
`
`
`
`
`
`
`
`Civil Action No. 2:15-cv-1455-WCB
`
`LEAD CASE
`
`
`
`
`TEVA PHARMACEUTICALS USA, INC.,
`ET AL.,
`
`
`v.
`
` Defendants.
`
`
`
`
`
`
`
`
`
`DEFENDANT TEVA PHARMACEUTICALS USA, INC.’S
`UNOPPOSED MOTION FOR TAXATION OF COSTS
`
`Defendant Teva Pharmaceuticals USA, Inc. (“Teva”) hereby moves for an order directing
`
`the Clerk of Court to tax costs against Plaintiffs Allergan, Inc. (“Allergan”) and The Saint Regis
`
`Mohawk Tribe in the amount of $35,938.32, as indicated in the attached bill of costs.
`
`In compliance with Local Rule CV-54(b), Counsel for Teva and Allergan met and
`
`conferred on November 3, 2017, in an effort to submit to the court an agreed bill of costs.
`
`On November 6, 2017, counsel for Teva submitted to counsel for Allergan the attached proposed
`
`bill of costs. Counsel for Allergan indicated it has no objections.
`
`Accordingly, Teva respectfully requests that the Court direct the Clerk to tax costs
`
`against Plaintiffs in the amount of $35,938.32.
`
`
`
`
`
`
`
`Case 2:15-cv-01455-WCB Document 536 Filed 11/06/17 Page 2 of 3 PageID #: 26190
`
`Dated: November 6, 2017
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/s/ J.C. Rozendaal
`J.C. Rozendaal (pro hac vice)
`Michael E. Joffre (pro hac vice)
`Pauline M. Pelletier (pro hac vice)
`R. Wilson Powers III (pro hac vice)
`William H. Milliken (pro hac vice)
`STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
`1100 New York Ave. NW, Suite 600
`Washington, DC 20005
`Tel: 202-371-2600
`Fax: 202-371-2540
`jcrozendaal@skgf.com
`mjoffre@skgf.com
`ppelletier@skgf.com
`tpowers@skgf.com
`wmilliken@skgf.com
`
`Louis B. (“Brady”) Paddock
`Texas Bar No. 00791394
`NIX, PATTERSON & ROACH L.L.P.
`2900 St. Michael Drive, Ste. 500
`Texarkana, TX 75503
`(903) 223-3999
`(903) 223-8520 (fax)
`bpaddock@nixlawfirm.com
`
`COUNSEL FOR DEFENDANT
`TEVA PHARMACEUTICALS USA, INC.
`
`
`
`Case 2:15-cv-01455-WCB Document 536 Filed 11/06/17 Page 3 of 3 PageID #: 26191
`
`
`
`CERTIFICATE OF SERVICE
`
`
`
`I hereby certify that a copy of the foregoing document was filed electronically in
`
`compliance with Local Rule CV-5(a). Therefore, this document was served on all counsel who
`
`are deemed to have consented to electronic service. Local Rule CV-5(a)(3)(A). Pursuant to Fed.
`
`R. Civ. P. 5(d) and Local Rule CV-5(d) and (e), all other counsel of record not deemed to have
`
`consented to electronic service were served with a true and correct copy of the foregoing by
`
`e-mail on November 6, 2017.
`
`/s/ J.C. Rozendaal
`J.C. Rozendaal
`
`
`CERTIFICATE OF COMPLIANCE
`
`
`
`In compliance with Local Rule CV-54(b), I hereby certify that on November 3, 2017, and
`
`November 6, 2017, Michael E. Joffre on behalf of Defendant Teva Pharmaceuticals USA, Inc.
`
`(“Teva”) met and conferred with Susan Morrison on behalf of Plaintiff Allergan, Inc
`
`(“Allergan”). Counsel for Allergan indicated it does not object to Teva’s proposed bill of costs.
`
`/s/ J.C. Rozendaal
`J.C. Rozendaal
`
`
`
`